Apex Biotechnology Statistics

Total Valuation

TPE:1733 has a market cap or net worth of TWD 3.19 billion. The enterprise value is 2.72 billion.

Market Cap	3.19B
Enterprise Value	2.72B

Important Dates

The next estimated earnings date is Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	May 17, 2024

Share Statistics

TPE:1733 has 99.95 million shares outstanding. The number of shares has increased by 0.08% in one year.

Current Share Class	n/a
Shares Outstanding	99.95M
Shares Change (YoY)	+0.08%
Shares Change (QoQ)	+0.43%
Owned by Insiders (%)	10.69%
Owned by Institutions (%)	4.90%
Float	76.55M

Valuation Ratios

The trailing PE ratio is 25.16.

PE Ratio	25.16
Forward PE	n/a
PS Ratio	1.72
PB Ratio	1.75
P/TBV Ratio	1.79
P/FCF Ratio	10.63
P/OCF Ratio	9.72
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.17, with an EV/FCF ratio of 9.05.

EV / Earnings	21.24
EV / Sales	1.47
EV / EBITDA	14.17
EV / EBIT	21.16
EV / FCF	9.05

Financial Position

The company has a current ratio of 3.44, with a Debt / Equity ratio of 0.07.

Current Ratio	3.44
Quick Ratio	2.00
Debt / Equity	0.07
Debt / EBITDA	0.64
Debt / FCF	0.41
Interest Coverage	35.27

Financial Efficiency

Return on equity (ROE) is 7.08% and return on invested capital (ROIC) is 4.12%.

Return on Equity (ROE)	7.08%
Return on Assets (ROA)	3.40%
Return on Invested Capital (ROIC)	4.12%
Return on Capital Employed (ROCE)	6.61%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.79
Inventory Turnover	1.89

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.19% in the last 52 weeks. The beta is 0.36, so TPE:1733's price volatility has been lower than the market average.

Beta (5Y)	0.36
52-Week Price Change	-5.19%
50-Day Moving Average	31.72
200-Day Moving Average	30.45
Relative Strength Index (RSI)	51.90
Average Volume (20 Days)	431,829

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPE:1733 had revenue of TWD 1.85 billion and earned 128.00 million in profits. Earnings per share was 1.27.

Revenue	1.85B
Gross Profit	521.34M
Operating Income	128.46M
Pretax Income	153.13M
Net Income	128.00M
EBITDA	182.03M
EBIT	128.46M
Earnings Per Share (EPS)	1.27

Full Income Statement

Balance Sheet

The company has 598.78 million in cash and 122.96 million in debt, giving a net cash position of 475.83 million or 4.76 per share.

Cash & Cash Equivalents	598.78M
Total Debt	122.96M
Net Cash	475.83M
Net Cash Per Share	4.76
Equity (Book Value)	1.82B
Book Value Per Share	18.25
Working Capital	1.17B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 328.67 million and capital expenditures -28.24 million, giving a free cash flow of 300.43 million.

Operating Cash Flow	328.67M
Capital Expenditures	-28.24M
Free Cash Flow	300.43M
FCF Per Share	3.01

Full Cash Flow Statement

Margins

Gross margin is 28.15%, with operating and profit margins of 6.94% and 6.91%.

Gross Margin	28.15%
Operating Margin	6.94%
Pretax Margin	8.27%
Profit Margin	6.91%
EBITDA Margin	9.83%
EBIT Margin	6.94%
FCF Margin	16.22%

Dividends & Yields

This stock pays an annual dividend of 1.20, which amounts to a dividend yield of 3.74%.

Dividend Per Share	1.20
Dividend Yield	3.74%
Dividend Growth (YoY)	-21.43%
Years of Dividend Growth	n/a
Payout Ratio	85.90%
Buyback Yield	-0.08%
Shareholder Yield	3.67%
Earnings Yield	4.01%
FCF Yield	9.41%

Dividend Details

Stock Splits

The last stock split was on July 1, 2009. It was a forward split with a ratio of 1.15.

Last Split Date	Jul 1, 2009
Split Type	Forward
Split Ratio	1.15

Scores

TPE:1733 has an Altman Z-Score of 5.15.

Altman Z-Score	5.15
Piotroski F-Score	n/a